kaal:claim:2317580-036

It is unclear whether corporations with CIAs will be uniformly affected, and future courts are likely to expand the basic legal duty of care only where the facts suggest that the CIA actually provided directors with more knowledge about compliance activities.

Source quote, verbatim

In light of the Pfizer precedent, future courts could hold directors of corporations that executed CIAs to a higher standard and thereby expand their basic legal duty of care if the facts suggest that CIAs provided directors with more knowledge about compliance activities.

From

Wulf A. Kaal, Elizabeth R. Malay, The Role of Corporate Integrity Agreements in the Expansion of Fiduciary Duties (2013), IV.2 Delineating the Role of CIAs in Fiduciary Duties, p. 18
https://ssrn.com/abstract=2317580 · source PDF

Cite as

Wulf A. Kaal, Elizabeth R. Malay, The Role of Corporate Integrity Agreements in the Expansion of Fiduciary Duties (2013). SSRN: https://ssrn.com/abstract=2317580

Holds when

future litigation following the Pfizer precedent
facts showing the CIA increased director knowledge

Classification

predictivesupport: speculativelaw-and-legal-systemscorporate-governance

Verify

The quote above is an exact substring of the source PDF, whose sha256 is 50973e1e820aef47a4e7ffdbdcb513d03f1845643fcf4fa5910e9528a0b7dac2. Extraction method: pdf-text-layer.
Attestation record: colloquium/attestations/8fc7b1177e82c2d2...json
Verify the binding yourself: curl -s https://wulfkaal.github.io/claims/2317580-036.md | sha256sum